FIELD: medicine, ophthalmology, pharmacy. SUBSTANCE: invention relates to ophthalmic drops providing an anti-inflammatory effect and containing the following components, weight/volume %: (a) diclofenac sodium 0.05-0.7; (b) γ-cyclodextrin 1-10; (c) polyvinylpyrrolidone 1-20; and (d) benzotonium chloride 0.002-0.01 or benzalkonium chloride 0.002-0.005, pH is at the range from 7.0 to 8.5. Anti-inflammatory drops can contain diclofenac sodium at the broad range of concentrations, they are stable for the long time and show weakly expressed irritating effect only. The composition provides the stability of ophthalmic drops at the storage. EFFECT: improved quality and properties of drops and composition. 6 cl, 4 tbl, 35 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AN AQUEOUS MEDICINAL COMPOSITION SHOWING CAPABILITY OF REVERSIBLE THERMOREGULATED GEL-FORMATION | 1993 |
|
RU2108112C1 |
| PHARMACEUTICAL COMPOSITION FOR TOPICAL USE FOR TREATMENT OF EYE AND NOSE ALLERGIC DISEASES | 1993 |
|
RU2130774C1 |
| EYE DROPS | 1991 |
|
RU2068260C1 |
| SOLID PHARMACEUTICAL PREPARATION OF MATRIX TYPE | 2008 |
|
RU2465916C2 |
| METHOD OF STABILIZATION OF PRANOPROFEN (VARIANTS) AND PRANOPROFEN-BASE STABLE AQUEOUS PREPARATION | 1995 |
|
RU2148402C1 |
| DRUG PREPARATION CONTAINING PRAR AGONIST | 2008 |
|
RU2449789C2 |
| ANTIALLERGIC PHARMACEUTICAL COMPOSITION FOR LOCAL OCULAR APPLICATION AND METHOD FOR ITS PRODUCTION | 1994 |
|
RU2107497C1 |
| AQUEOUS OPHTHALMIC SUSPENSION OF CRYSTAL REBAMIPIDE | 2005 |
|
RU2398585C2 |
| PRESERVATIVE COMPOSITION FOR OPHTHALMIC APPLICATION | 2006 |
|
RU2413534C2 |
| LIQUID AQUEOUS OPHTHALMIC COMPOSITION | 2007 |
|
RU2445950C2 |
